Evidence map›Paper›PMID 33731935›Full record

ArticleNature2021

Publisher Correction: LifeTime and improving European healthcare through cell-based interceptive medicine.

Nikolaus Rajewsky, Geneviève Almouzni, Stanislaw A Gorski, Stein Aerts, Ido Amit, Michela G Bertero, Christoph Bock, Annelien L Bredenoord, Giacomo Cavalli, Susanna Chiocca and 41 more

Abstract readPublished Erratum
In one paragraph

Article in Nature, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

51 authors.

Nikolaus Rajewsky *Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany. rajewsky@mdc-berlin.de.ORCID http://orcid.org/0000-0002-4785-4332
Geneviève Almouzni *Institut Curie, CNRS, PSL Research University, Sorbonne Université, Nuclear Dynamics Unit, Equipe Labellisée Ligue contre le cancer, Paris, France. genevieve.almouzni@curie.fr.ORCID http://orcid.org/0000-0001-5570-0723
Stanislaw A Gorski *Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany. stan.gorski@mdc-berlin.de.ORCID http://orcid.org/0000-0003-0539-3395
Stein AertsVIB Center for Brain and Disease Research, Leuven, Belgium.ORCID http://orcid.org/0000-0002-8006-0315
Ido AmitDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0003-2968-877X
Michela G BerteroCentre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Barcelona, Spain.
Christoph BockCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID http://orcid.org/0000-0001-6091-3088
Annelien L BredenoordDepartment of Medical Humanities, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-7542-8963
Giacomo CavalliInstitute of Human Genetics, UMR 9002, CNRS and University of Montpellier, Montpellier, France.ORCID http://orcid.org/0000-0003-3709-3469
Susanna ChioccaDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID http://orcid.org/0000-0002-9721-0850
Hans CleversHubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-3077-5582
Bart De StrooperVIB Center for Brain and Disease Research, Leuven, Belgium.
Angelika EggertBerlin Institute of Health (BIH), Berlin, Germany.
Jan EllenbergCell Biology and Biophysics Unit, European Molecular Biology Laboratory, Heidelberg, Germany.ORCID http://orcid.org/0000-0001-5909-701X
Xosé M FernándezInstitut Curie, PSL Research University, Paris, France.ORCID http://orcid.org/0000-0001-7139-6215
Marek FiglerowiczInstitute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland.
Susan M GasserFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.ORCID http://orcid.org/0000-0003-3610-9123
Norbert HubnerCharité-Universitätsmedizin, Berlin, Germany.ORCID http://orcid.org/0000-0002-1218-6223
Jørgen KjemsDepartment of Molecular Biology and Genetics (MBG), Aarhus University, Aarhus, Denmark.
Jürgen A KnoblichInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.ORCID http://orcid.org/0000-0002-6751-3404
Grietje KrabbeBerlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Peter LichterDivision of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0002-2960-5279
Sten LinnarssonDivision of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-3491-3444
Jean-Christophe MarineLaboratory for Molecular Cancer Biology, VIB Center for Cancer Biology, KU Leuven, Leuven, Belgium.
John C MarioniEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK.ORCID http://orcid.org/0000-0001-9092-0852
Marc A Marti-RenomCentre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID http://orcid.org/0000-0002-0151-4279
Mihai G NeteaDepartment of Internal Medicine, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0003-2421-6052
Dörthe NickelInstitut Curie, PSL Research University, Paris, France.
Marcelo NollmannCentre de Biochimie Structurale, CNRS UMR 5048, INSERM U1054, Université de Montpellier, Montpellier, France.ORCID http://orcid.org/0000-0003-3339-2349
Halina R NovakVIB Technology Watch, Ghent, Belgium.
Helen ParkinsonEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK.
Stefano PiccoloDepartment of Molecular Medicine, University of Padua School of Medicine, Padua, Italy.ORCID http://orcid.org/0000-0002-1600-3092
Inês PinheiroInstitut Curie, CNRS, PSL Research University, Sorbonne Université, Nuclear Dynamics Unit, Equipe Labellisée Ligue contre le cancer, Paris, France.
Ana PomboBerlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.ORCID http://orcid.org/0000-0002-7493-6288
Christian PoppBerlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Wolf ReikWellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.ORCID http://orcid.org/0000-0003-0216-9881
Sergio Roman-RomanDepartment of Translational Research, Institut Curie, PSL Research University, Paris, France.
Philip RosenstielInstitute of Clinical Molecular Biology, Kiel University, Kiel, Germany.
Joachim L SchultzeLife and Medical Sciences Institute (LIMES), University of Bonn, Bonn, Germany.ORCID http://orcid.org/0000-0003-2812-9853
Oliver StegleEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK.
Amos TanayDepartment of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0001-9419-3824
Giuseppe TestaDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Dimitris ThanosBiomedical Research Foundation, Academy of Athens, Athens, Greece.
Fabian J TheisInstitute of Computational Biology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.ORCID http://orcid.org/0000-0002-2419-1943
Maria-Elena Torres-PadillaInstitute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München - German Research Center for Environmental Health, Munich, Germany.ORCID http://orcid.org/0000-0002-1020-2074
Alfonso ValenciaICREA, Barcelona, Spain.
Céline VallotDepartment of Translational Research, Institut Curie, PSL Research University, Paris, France.ORCID http://orcid.org/0000-0003-1601-2359
Alexander van OudenaardenHubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-9442-3551
Marie VidalBerlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.ORCID http://orcid.org/0000-0003-1186-9994
Thierry VoetDepartment of Human Genetics, KU Leuven, Leuven, Belgium.
LifeTime Community Working Groups

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33731935
PMCPMC8009763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.